See also this year's filing and all EDGAR filings for this company.
PDF Report 0001832168_2023_Longboard_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001832168, Longboard Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 69,838,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 9,000 |
| 3 | remainder_Assets | 769,000 |
| 4 | LiabilitiesCurrent | 8,764,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,160,000 |
| 9 | ResearchAndDevelopmentExpense | 34,638,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 853,000 |
| 13 | remainder_ComprehensiveNetIncome | -528,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 70,616,000 |
| 1 | Liabilities | 8,764,000 |
| 2 | Expenses | 44,798,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 61,852,000 |
| 5 | NetIncome | -43,945,000 |
| 6 | ComprehensiveNetIncome | -44,209,000 |
| 7 | BaseVar | 62,779,500 |
| 8 | EconomicCapitalRatio | 1.57 |